Recs

1

Why This Biotech Shakeup Didn't Stir Investors

Recently, one of the biggest biotech dividend stocks, PDL BioPharma (Nasdaq: PDLI  ) , announced that its CFO has left the company for "personal reasons." While investors are always wary of management shakeups, this move had little effect on the company's share price.

In the following video, health-care analysts Max Macaluso and Brenton Flynn discuss this move and one issue PDL BioPharma investors must continue to keep a close eye on.

While you can certainly make huge gains in biotech and pharmaceuticals, the best investing approach is to choose great companies and stick with them for the long term. In our free report "3 Stocks That Will Help You Retire Rich," we name stocks that could help you build long-term wealth and retire well, along with some winning wealth-building strategies that every investor should be aware of. Click here now to keep reading.


Read/Post Comments (0) | Recommend This Article (1)

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2139320, ~/Articles/ArticleHandler.aspx, 8/29/2016 7:36:36 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,502.99 107.59 0.58%
S&P 500 2,180.38 11.34 0.52%
NASD 5,232.33 13.41 0.26%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

8/29/2016 4:00 PM
PDLI $2.84 Down -0.02 -0.70%
PDL BioPharma CAPS Rating: ***
BIIB $306.13 Down -2.04 -0.66%
Biogen CAPS Rating: *****
ELN.DL2 $0.00 Down +0.00 +0.00%
Elan CAPS Rating: ***

Advertisement